<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Hsu | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/donkeypriest9/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/donkeypriest9/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Hsu.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">ae14d7a88fa751a31bdebcd0c2652362</guid>
				<title>Hsu posted an update: CD5-2 treatment also contributed to the reorganisation of [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/41445/</link>
				<pubDate>Sat, 08 Feb 2025 08:57:40 -0800</pubDate>

									<content:encoded><![CDATA[<p>CD5-2 treatment also contributed to the reorganisation of the cytoskeleton, inducing reorganisation of stress fibres to circumferential actin, which previously has been described as associated with the stabilisation of the endothelial barrier, and amplification of the transcellular migration of CD8+ T cells. Thus, we propose that promotion of&hellip;<span class="activity-read-more" id="activity-read-more-41445"><a href="http://www.nationalboardinstitute.com/activity/p/41445/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">ae26dcc827a2fdda3293460c0ab32de2</guid>
				<title>Hsu posted an update: Individuals with substance use disorders (SUDs), including [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/39694/</link>
				<pubDate>Thu, 06 Feb 2025 09:39:31 -0800</pubDate>

									<content:encoded><![CDATA[<p>Individuals with substance use disorders (SUDs), including those in long-term recovery, and their loved ones are facing rapid changes to treatment and support services due to COVID-19. To assess these changes, the Addiction Policy Forum fielded a survey to their associated patient and family networks between April 27 and May 13, 2020. Individuals&hellip;<span class="activity-read-more" id="activity-read-more-39694"><a href="http://www.nationalboardinstitute.com/activity/p/39694/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">59c3b5634386d62902b5f5d3eac09309</guid>
				<title>Hsu posted an update: OBJECTIVES To better characterize the clinicopathologic [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/38133/</link>
				<pubDate>Tue, 04 Feb 2025 09:41:17 -0800</pubDate>

									<content:encoded><![CDATA[<p>OBJECTIVES To better characterize the clinicopathologic presentation and outcomes of follicular lymphoma with MYC and BCL2 and/or BCL6 rearrangements (double-hit and triple-hit follicular lymphoma), we present three cases from our institution and perform a literature review of 37 published cases. METHODS Cases were identified using institutional&hellip;<span class="activity-read-more" id="activity-read-more-38133"><a href="http://www.nationalboardinstitute.com/activity/p/38133/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">0a2983331fdb8bbb2772c6b4c20e344a</guid>
				<title>Hsu posted an update: AMR CQUIN data were submitted by 88% of trusts for at least [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/36370/</link>
				<pubDate>Sun, 02 Feb 2025 09:55:18 -0800</pubDate>

									<content:encoded><![CDATA[<p>AMR CQUIN data were submitted by 88% of trusts for at least one quarter of 2016-17. Approximately 92% of prescriptions had an indication documented and 87.5% of prescriptions had evidence of review within 72 h; these increased by 7 and 10 percentage points respectively between the first and final quarters.</p>
<p> The AMS surveillance system&hellip;<span class="activity-read-more" id="activity-read-more-36370"><a href="http://www.nationalboardinstitute.com/activity/p/36370/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">81dc4b68550553119a765a8f68bf1993</guid>
				<title>Hsu posted an update: Due to the poor controlled release ability, bio-based [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/34511/</link>
				<pubDate>Fri, 31 Jan 2025 09:20:37 -0800</pubDate>

									<content:encoded><![CDATA[<p>Due to the poor controlled release ability, bio-based materials are difficult for large scale application on controlled release fertilizers (CRFs). Starch-based polyol (SP) and castor oil (CO) were mutually modified, and a cross-linked polymer film was formed on the surface of urea by in-situ reaction, which improved the slow release ability of&hellip;<span class="activity-read-more" id="activity-read-more-34511"><a href="http://www.nationalboardinstitute.com/activity/p/34511/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">2af6ada119dac7bf4b9aab864d03e640</guid>
				<title>Hsu posted an update: With many drugs being tried in the management and treatment [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/33474/</link>
				<pubDate>Thu, 30 Jan 2025 09:32:14 -0800</pubDate>

									<content:encoded><![CDATA[<p>With many drugs being tried in the management and treatment of COVID-19, dupilumab is one such monoclonal antibody that has come under the limelight for its possible role as an adjunct therapy in COVID-19 position. There are isolated case reports and series that document a milder course of COVID-19 infection in patients who have already been on&hellip;<span class="activity-read-more" id="activity-read-more-33474"><a href="http://www.nationalboardinstitute.com/activity/p/33474/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f33e527702dcbe52bf554b88b87e4bc7</guid>
				<title>Hsu posted an update: Caffeic acid 3,4-dihydroxyphenethyl ester (CADPE) is a [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/29895/</link>
				<pubDate>Tue, 28 Jan 2025 14:12:49 -0800</pubDate>

									<content:encoded><![CDATA[<p>Caffeic acid 3,4-dihydroxyphenethyl ester (CADPE) is a natural polyphenolic ester isolated as a minor component from a water extract of the Chinese medicine Zhongjiefeng [Sarcandra glabra (Thunb.) Nakai (Chloranthaceae)] and has previously shown to have activity against solid tumors through the modulation of multiple targets or signal pathways.&hellip;<span class="activity-read-more" id="activity-read-more-29895"><a href="http://www.nationalboardinstitute.com/activity/p/29895/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">84e198cd6446d7487caf7f8c785da6e9</guid>
				<title>Hsu became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/29864/</link>
				<pubDate>Tue, 28 Jan 2025 14:09:23 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>